Christine Mikail Cvijic
CFO, President at Neurogene Inc. (NGNE)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 7SEC | NGNENeurogene Inc. | Sell Plan | 60088,240 held (−1%) | $36.02 | $22K | -26.7% |
| Jul 7SEC | NGNENeurogene Inc. | Sell Plan | 4,20084,040 held (−5%) | $36.13 | $152K | -26.9% |
| Jul 2SEC | NGNENeurogene Inc. | Sell Plan | 73992,901 held (−1%) | $34.06 | $25K | -22.5% |
| Jul 2SEC | NGNENeurogene Inc. | Sell Plan | 2,53190,370 held (−3%) | $34.58 | $88K | -23.7% |
| Jul 2SEC | NGNENeurogene Inc. | Sell Plan | 1,53088,840 held (−2%) | $35.23 | $54K | -25.1% |
| May 8SEC | NGNENeurogene Inc. | Sell Plan | 4,80098,440 held (−5%) | $30.07 | $144K | -12.2% |
| May 8SEC | NGNENeurogene Inc. | Sell Plan | 4,80093,640 held (−5%) | $32.44 | $156K | -18.6% |
| Mar 30SEC | NGNENeurogene Inc. | Sell Plan | 2,558103,240 held (−2%) | $21.62 | $55K | +22.1% |
| Mar 17SEC | NGNENeurogene Inc. | Sell Plan | 2,387107,456 held (−2%) | $20.42 | $49K | +29.3% |
| Mar 17SEC | NGNENeurogene Inc. | Sell Plan | 1,395106,061 held (−1%) | $21.25 | $30K | +24.2% |
| Mar 17SEC | NGNENeurogene Inc. | Sell Plan | 263105,798 held (−0%) | $22.02 | $6K | +19.9% |
| Mar 3SEC | NGNENeurogene Inc. | Sell Plan | 4,800109,843 held (−4%) | $25.11 | $121K | +5.1% |
- Sell
CFO, President Christine Mikail Cvijic sold $22K of NGNE at $36.02 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO, President Christine Mikail Cvijic sold $152K of NGNE at $36.13 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO, President Christine Mikail Cvijic sold $25K of NGNE at $34.06 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO, President Christine Mikail Cvijic sold $88K of NGNE at $34.58 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO, President Christine Mikail Cvijic sold $54K of NGNE at $35.23 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO, President Christine Mikail Cvijic sold $144K of NGNE at $30.07 — pre-scheduled 10b5-1 plan sale.